悦心健康：10月24日召开董事会会议

Group 1 - The company Yueshen Health announced that its 18th meeting of the 8th board of directors will be held on October 24, 2025, in Shanghai, where the Q3 2025 report will be reviewed [1] - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a strong performance in the biopharmaceutical secondary market [1]